Return to content in this issue

 

Protocol for Successful Desensitization to Ivacaftor and Elexacaftor/Tezacaftor/Ivacaftor in a Delayed Hypersensitivity Reaction Confirmed by the Lymphocyte Transformation Test

Mir-Ihara P1, De Las Vecillas L1,2,3, Heredia R1, Fiandor A1,2,3, González-Muñoz M2,4, Zamarrón E2,5, Prados C2,5, Cabañas R1,2,3,6

1Allergy Department, Hospital Universitario La Paz, Madrid, Spain
2Hospital La Paz Institute for Health Research (IdiPAZ), Madrid, Spain
3PIELenRed Consortium
4Immunology Department, Hospital Universitario La Paz, Madrid, Spain
5Pulmonology Department, Hospital Universitario La Paz, Madrid, Spain
6Center for Biomedical Research Network on Rare Diseases (CIBERER U754), Madrid, Spain

J Investig Allergol Clin Immunol 2024; Vol 34(3) : 211-213
doi: 10.18176/jiaci.0961

Key words: Cystic fibrosis, Cystic fibrosis transmembrane conductance modulators, Desensitization, Delayed hypersensitivity, Lymphocyte transformation test